Sarepta Therapeutics files Form 13F with zero total value

Sarepta Therapeutics, Inc. filed a Form 13F as an institutional investment manager, indicating it is submitting a 13F holdings report.

Rhea-AI Filing Summary

Sarepta Therapeutics, Inc. filed a Form 13F as an institutional investment manager, indicating it is submitting a 13F holdings report. The summary page shows 1 information table entry with an aggregate reported value of $0, and no other included managers listed. The report is signed by Executive Vice President and Chief Financial Officer Ryan Wong.

Key Figures

Form 13F Information Table Entry Total: 1 Form 13F Information Table Value Total: 0 Number of Other Included Managers: 0

3 metrics

Form 13F Information Table Entry Total 1 Total number of entries in the Form 13F information table

Form 13F Information Table Value Total 0 Aggregate value of reportable holdings, rounded to nearest dollar

Number of Other Included Managers 0 Count of additional managers included in this Form 13F report

Key Terms

Form 13F, Institutional Investment Manager, 13F HOLDINGS REPORT

3 terms

Form 13F regulatory

"FORM 13F FORM 13F COVER PAGE"

A Form 13F is a quarterly filing that large investment managers must submit to disclose their holdings in publicly traded stocks and certain other securities. It acts like a peek into the portfolios of big investors, helping other market participants see what large players are buying or selling and offering clues about investment trends, crowded trades, and potential market impact.

Institutional Investment Manager regulatory

"The institutional investment manager filing this report"

13F HOLDINGS REPORT regulatory

"Report Type (Check only one.) X | 13F HOLDINGS REPORT."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sarepta Therapeutics (SRPT) file with the SEC in this document?

Sarepta Therapeutics filed a Form 13F holdings report as an institutional investment manager, disclosing a summary with one information table entry and an aggregate reported value of $0 for its reportable positions.

How many holdings entries did Sarepta Therapeutics (SRPT) report on its Form 13F?

The Form 13F summary shows 1 information table entry in total. This means Sarepta reported one line item in its 13F information table, although the aggregate value for these reportable holdings is listed as $0.

What total value of securities did Sarepta Therapeutics (SRPT) report on Form 13F?

The Form 13F summary lists a Form 13F Information Table Value Total of $0. This figure is rounded to the nearest dollar and represents the aggregate reported value of the manager’s reportable 13F holdings for the period.

Are there any other included managers in Sarepta Therapeutics’ (SRPT) Form 13F report?

No. The report summary shows the Number of Other Included Managers is 0, and the separate section listing other included managers states “NONE”, indicating no additional managers are part of this filing.

Who signed the Sarepta Therapeutics (SRPT) Form 13F and in what capacity?

The Form 13F is signed by Ryan Wong, who is identified as Executive Vice President, Chief Financial Officer. The signature block indicates he is authorized to submit the report and certify that the information provided is true, correct, and complete.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 06:07 AM Accepted by SEC EDGAR 08/13/2026 - 07:10 PM Learn about SEC filing dates

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended: 06-30-2026

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	Sarepta Therapeutics, Inc.
Address:	215 First Street
	Suite 415
	Cambridge, MA 02142
Form 13F File Number:	028-26297
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:		Ryan Wong
Title:		Executive Vice President, Chief Financial Officer
Phone:		617-274-4000
Signature, Place, and Date of Signing:
/s/ Ryan Wong			Las Vegas, NV	08-13-2026
[Signature]			[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:		0
	Form 13F Information Table Entry Total:		1
	Form 13F Information Table Value Total:		0
			(round to nearest dollar)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

NONE